Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
PROG | PRG | Nov 25, 2024 | 48.08 | +1.37 |
Progress Software | PRGS | Nov 25, 2024 | 69.89 | +0.92 |
Progressive | PGR | Nov 25, 2024 | 265.88 | -0.07 |
Progyny | PGNY | Nov 25, 2024 | 15.75 | +2.01 |
ProKidney | PROK | Nov 25, 2024 | 1.83 | +8.28 |
Prologis | PLD | Nov 25, 2024 | 118.07 | +1.96 |
ProMIS Neurosciences | PMN | Nov 25, 2024 | 0.92 | -10.64 |
PropertyGuru | PGRU | Nov 25, 2024 | 6.64 | 0.00 |
ProPetro | PUMP | Nov 25, 2024 | 8.45 | -0.59 |
ProPhase Labs | PRPH | Nov 25, 2024 | 0.74 | -3.17 |
ProQR Therapeutics | PRQR | Nov 25, 2024 | 3.54 | -2.21 |
PROS | PRO | Nov 25, 2024 | 24.05 | +0.54 |
ProShares Bitcoin Strategy ETF | BITO | Nov 25, 2024 | 25.48 | -4.53 |
Proshares Ultra FTSE Europe | UPV | Nov 25, 2024 | 57.30 | +1.13 |
ProShares UltraShort Bloomberg Natural Gas | KOLD | Nov 25, 2024 | 57.18 | -7.22 |
Proshares Ultrashort FTSE Europe | EPV | Nov 25, 2024 | 40.34 | -1.71 |
Prospect Capital | PSEC | Nov 25, 2024 | 4.81 | -0.41 |
Prospect Capital A Pref | PSEC-A | Nov 25, 2024 | 19.32 | +0.91 |
Prosperity Bancshares | PB | Nov 25, 2024 | 85.07 | +0.91 |
Protagenic Therapeutics | PTIX | Nov 25, 2024 | 0.65 | -0.62 |
Protagonist Therapeutics | PTGX | Nov 25, 2024 | 45.53 | -2.00 |
Protalix Bio Therapeutics | PLX | Nov 25, 2024 | 1.71 | +1.18 |
Protara Therapeutics | TARA | Nov 25, 2024 | 2.60 | +8.79 |
Prothena | PRTA | Nov 25, 2024 | 15.08 | +3.29 |
Proto Labs | PRLB | Nov 25, 2024 | 41.12 | -0.92 |
Provident Bancorp | PVBC | Nov 25, 2024 | 11.58 | +1.67 |
Provident Financial | PROV | Nov 25, 2024 | 15.90 | +1.15 |
Provident Financial Services | PFS | Nov 25, 2024 | 21.66 | +1.22 |
Prudential ADR | PUK | Nov 25, 2024 | 16.37 | +2.76 |
Prudential Financial | PRU | Nov 25, 2024 | 128.71 | +0.64 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.